However, in our population, the female:male ratio is 1:2, only one patient with CNS at diagnosis had liver metastasis and only one was affected by tumor-carrying MYCN amplification; on the other hand, all patients had diffuse metastatic disease with skull involvement at diagnosis. The gene discussed is MYCN; the disease is neoplasm.